Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $10.03 in the prior trading day, Nu Skin Enterprises, Inc (NYSE: NUS) closed at $10.05, up 0.20%. In other words, the price has increased by $0.20 from its previous closing price. On the day, 0.19 million shares were traded. NUS stock price reached its highest trading level at $10.16 during the session, while it also had its lowest trading level at $9.96.
Ratios:
Our goal is to gain a better understanding of NUS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.94 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.18. For the most recent quarter (mrq), Quick Ratio is recorded 1.45 and its Current Ratio is at 2.15. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In the most recent recommendation for the company, Jefferies on January 31, 2023, Downgraded its rating to Hold and sets its target price to $39 from $43 previously.
BofA Securities Upgraded its Underperform to Neutral on October 02, 2020, whereas the target price for the stock was revised from $54 to $58.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’25 when Hatchett Steven Keith bought 5,500 shares for $9.61 per share. The transaction valued at 52,855 led to the insider holds 167,565 shares of the business.
Nathanson Laura sold 6,489 shares of NUS for $79,296 on Sep 04 ’25. The Director now owns 33,149 shares after completing the transaction at $12.22 per share. On Sep 03 ’25, another insider, Clark Chayce David, who serves as the EVP and General Counsel of the company, sold 20,000 shares for $11.97 each. As a result, the insider received 239,400 and left with 233,140 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUS now has a Market Capitalization of 489938272 and an Enterprise Value of 557211264. As of this moment, Nu’s Price-to-Earnings (P/E) ratio for their current fiscal year is 4.62, and their Forward P/E ratio for the next fiscal year is 7.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31 while its Price-to-Book (P/B) ratio in mrq is 0.62. Its current Enterprise Value per Revenue stands at 0.357 whereas that against EBITDA is 3.594.
Stock Price History:
The Beta on a monthly basis for NUS is 0.98, which has changed by 0.47500002 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, NUS has reached a high of $14.62, while it has fallen to a 52-week low of $5.32. The 50-Day Moving Average of the stock is -1.85%, while the 200-Day Moving Average is calculated to be 9.36%.
Shares Statistics:
The stock has traded on average 476.80K shares per day over the past 3-months and 540650 shares per day over the last 10 days, according to various share statistics. A total of 49.10M shares are outstanding, with a floating share count of 47.52M. Insiders hold about 2.51% of the company’s shares, while institutions hold 75.03% stake in the company. Shares short for NUS as of 1764288000 were 2386132 with a Short Ratio of 4.82, compared to 1761868800 on 2306342. Therefore, it implies a Short% of Shares Outstanding of 2386132 and a Short% of Float of 4.96.
Dividends & Splits
In the trailing 12 months, NUS’s forward annual dividend rate was 0.24, compared to 0.24 this year. Against a Trailing Annual Dividend Yield of 0.023928216. The stock’s 5-year Average Dividend Yield is 4.56.
